Jane Street Group, LLC Allogene Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$7.65 - $15.29 $13,770 - $27,522	-1,800 Reduced 13.04%	12,000 $109,000
Q4 2021 Feb 15, 2022	BUY	$13.13 - $24.52 $55,146 - $102,984	4,200 Added 43.75%	13,800 $206,000
Q2 2021 Aug 16, 2021	BUY	$23.49 - $35.8 $93,960 - $143,200	4,000 Added 71.43%	9,600 $250,000
Q2 2020 Aug 17, 2020	BUY	$18.39 - $54.04 $102,984 - $302,624	5,600 New	5,600 $240,000

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.